Delirium, Dementia, Amnestic, Cognitive Disorders  >>  rosiglitazone  >>  Phase 1
Welcome,         Profile    Billing    Logout  

5 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
rosiglitazone / Generic mfg.
NCT00468897: A Study To Demonstrate The Bioequivalence Of Rosiglitazone XR (BRL-049653) 8mgs XR Manufactured At Two Different Sites.

Completed
1
50
Europe
RSG XR, BRL-049653
GlaxoSmithKline
Alzheimer's Disease
05/07
05/07
Cocktail, NCT00692510: Drug Interaction Study Between AZD3480 and Cytochrome P450

Completed
1
18
Europe
AZD3480, Placebo, Cocktail mix (Caffeine, Bupropion, Rosiglitazone, Omeprazole, Midazolam, Bilirubin)
AstraZeneca
Metabolism, Alzheimer's Disease
09/08
09/08
NCT00688207: Mild Alzheimer''s Disease to Assess the of Extended Release Formulation of Rosiglitazone (RSG XR)

Completed
1
14
Europe
Rosiglitazone (Extended Release)
GlaxoSmithKline
Alzheimer's Disease
09/08
09/08
NCT00733785: PK, Dose Proportionality, Food Effect And Repeat Dose Study Of Rosiglitazone XR In Healthy Volunteers

Completed
1
60
Europe
Rosiglitazone XR
GlaxoSmithKline
Alzheimer's Disease
11/08
11/08
NCT00884533: QTc Study of Rosi XR in Healthy Volunteers

Withdrawn
1
0
US, Europe
Rosi XR, Placebo, Moxifloxacin
GlaxoSmithKline
Alzheimer's Disease
08/09
08/09

Download Options